Abstract
Myocardial infarction has been carefully studied in numerous experimental models. Most of these models are based on electrophysiological and functional data, and pay less attention to histological discoveries. During the last decade, treatment using advanced therapies, mainly cell therapy, has prevailed from among all the options to be studied for treating myocardial infarction. In our study we wanted to show the fundamental histological parameters to be evaluated during the development of an infarction on an experimental model as well as treatment with mesenchymal stem cells derived from adipose tissue applied intra-lesionally. The fundamental parameters to study in infarcted tissue at the histological level are the cells involved in the inflammatory process (lymphocytes, macrophages and M2, neutrophils, mast cells and plasma cells), neovascularization processes (capillaries and arterioles) and cardiac cells (cardiomyocytes and Purkinje fibers). In our study, we used intramyocardial injection of mesenchymal stem cells into the myocardial infarction area 1 hour after arterial occlusion and allowed 1 month of evolution before analyzing the modifications on the normal tissue inflammatory infiltrate. Acute inflammation was shortened, leading to chronic inflammation with abundant plasma cells and mast cells and complete disappearance of neutrophils. Another benefit was an increase in the number of vessels formed. Cardiomyocytes and Purkinje fibers were better conserved, both from a structural and metabolic point of view, possibly leading to reduced morbidity in the long term. With this study we present the main histological aspects to be evaluated in future assays, complementing or explaining the electrophysiological and functional findings.
Highlights
Many attempts have been made to develop a treatment for heart failure using experimental models of myocardial infarction (MI)
Nine Landrace-Large White pigs 23–28 kg were used: one was male -used to obtain adipose-derived mesenchymal stem cells (ASCs) from subcutaneous adipose tissue- and the rest were females destined for the intervention
We found more arterioles in the scarring region of the hearts belonging to the MI + ASC group than in the MIC group (Figs. 3A–3B)
Summary
Many attempts have been made to develop a treatment for heart failure using experimental models of myocardial infarction (MI). The attempts that have reached clinical trial phases have used mesenchymal stem cells (MSCs). MSCs are immunoprivileged cells that are suitable for allogeneic and xenogeneic transplantation (Aggarwal & Pittenger, 2005). As immunomodulatory cells, they act on the injured or inflamed area by secreting various growth factors. They act on the injured or inflamed area by secreting various growth factors To do so, they stimulate the proliferation of local cells which helps with remodeling the local matrix. MSC-based therapies present a promising treatment plan for decreasing morbidity and mortality from chronic diseases with poor wound healing (García-Gómez et al, 2010)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.